<DOC>
	<DOC>NCT00337610</DOC>
	<brief_summary>A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic (blood sugar) control on metformin therapy.</brief_summary>
	<brief_title>Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient has type 2 diabetes mellitus Males Females who are highly unlikely to become pregnant Patients poorly controlled while taking one or two oral antidiabetic medications Patient has a history of type 1 diabetes mellitus or history of ketoacidosis Patient required insulin therapy within the prior 8 weeks Patient is on or has been taking Thiazolidinediones (TZDs) such as Actos® (pioglitazone) or Avandia® (rosiglitazone) or is on or has been taking Byetta® (exenatide) within the prior 12 weeks of the screening visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>